Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

(1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors.

Vázquez-Fresno R, Llorach R, Alcaro F, Rodríguez MÁ, Vinaixa M, Chiva-Blanch G, Estruch R, Correig X, Andrés-Lacueva C.

Electrophoresis. 2012 Aug;33(15):2345-54. doi: 10.1002/elps.201100646.

PMID:
22887155
2.

[Alcohol and wine and cardiovascular diseases in epidemiologic studies].

Sinkiewicz W, Weglarz M.

Przegl Lek. 2009;66(5):233-8. Review. Polish.

PMID:
19739580
3.

The relationship between wine consumption and cardiovascular risk: from epidemiological evidence to biological plausibility.

Rotondo S, Di Castelnuovo A, de Gaetano G.

Ital Heart J. 2001 Jan;2(1):1-8. Review.

PMID:
11214695
4.

Wine and health: state of proofs and research needs.

Walzem RL.

Inflammopharmacology. 2008 Dec;16(6):265-71. doi: 10.1007/s10787-008-8027-6. Review.

PMID:
19109750
5.

Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption.

de Gaetano G, De Curtis A, di Castelnuovo A, Donati MB, Iacoviello L, Rotondo S.

Ann N Y Acad Sci. 2002 May;957:174-88. Review.

PMID:
12074971
6.

Alcohol, red wine and cardiovascular disease.

Wollin SD, Jones PJ.

J Nutr. 2001 May;131(5):1401-4. Review.

7.

The cardiovascular implications of alcohol and red wine.

Saremi A, Arora R.

Am J Ther. 2008 May-Jun;15(3):265-77. doi: 10.1097/MJT.0b013e3180a5e61a. Review.

PMID:
18496264
8.

[Cultural history of wine, the theoretical background of wine therapy].

Fehér J, Lengyel G, Lugasi A.

Orv Hetil. 2005 Dec 25;146(52):2635-9. Review. Hungarian.

PMID:
16468605
9.

Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks.

van de Wiel A, de Lange DW.

Neth J Med. 2008 Dec;66(11):467-73. Review.

10.

Global metabolic profiling for the study of alcohol-related disorders.

Gika HG, Wilson ID.

Bioanalysis. 2014 Jan;6(1):59-77. doi: 10.4155/bio.13.301. Review.

PMID:
24341495
11.

Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans.

Covas MI, Gambert P, Fitó M, de la Torre R.

Atherosclerosis. 2010 Feb;208(2):297-304. doi: 10.1016/j.atherosclerosis.2009.06.031. Epub 2009 Jul 8. Review.

PMID:
19660752
12.

An Integrated View of the Effects of Wine Polyphenols and Their Relevant Metabolites on Gut and Host Health.

Cueva C, Gil-Sánchez I, Ayuda-Durán B, González-Manzano S, González-Paramás AM, Santos-Buelga C, Bartolomé B, Moreno-Arribas MV.

Molecules. 2017 Jan 6;22(1). pii: E99. doi: 10.3390/molecules22010099. Review.

13.

The health benefits of wine.

German JB, Walzem RL.

Annu Rev Nutr. 2000;20:561-93. Review.

PMID:
10940346
14.

Urine metabolomics.

Zhang A, Sun H, Wu X, Wang X.

Clin Chim Acta. 2012 Dec 24;414:65-9. doi: 10.1016/j.cca.2012.08.016. Epub 2012 Aug 25. Review.

PMID:
22971357
15.

Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.

Cheng S, Shah SH, Corwin EJ, Fiehn O, Fitzgerald RL, Gerszten RE, Illig T, Rhee EP, Srinivas PR, Wang TJ, Jain M; American Heart Association Council on Functional Genomics and Translational Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Stroke Council..

Circ Cardiovasc Genet. 2017 Apr;10(2). pii: e000032. doi: 10.1161/HCG.0000000000000032. Review.

PMID:
28360086
16.

The food metabolome: a window over dietary exposure.

Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted LO, Draper J, Rappaport SM, van der Hooft JJ, Wishart DS.

Am J Clin Nutr. 2014 Jun;99(6):1286-308. doi: 10.3945/ajcn.113.076133. Epub 2014 Apr 23. Review.

17.

1H NMR-metabolomics: can they be a useful tool in our understanding of cardiac arrest?

Chalkias A, Fanos V, Noto A, Castrén M, Gulati A, Svavarsdóttir H, Iacovidou N, Xanthos T.

Resuscitation. 2014 May;85(5):595-601. doi: 10.1016/j.resuscitation.2014.01.025. Epub 2014 Feb 7. Review.

PMID:
24513156
18.

Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.

Barderas MG, Laborde CM, Posada M, de la Cuesta F, Zubiri I, Vivanco F, Alvarez-Llamas G.

J Biomed Biotechnol. 2011;2011:790132. doi: 10.1155/2011/790132. Epub 2011 Jan 2. Review.

19.

Metabolomics in biomarker discovery: future uses for cancer prevention.

Kim YS, Maruvada P, Milner JA.

Future Oncol. 2008 Feb;4(1):93-102. doi: 10.2217/14796694.4.1.93. Review.

PMID:
18241004
20.

Metabolomic biomarkers for obesity in humans: a short review.

Rauschert S, Uhl O, Koletzko B, Hellmuth C.

Ann Nutr Metab. 2014;64(3-4):314-24. doi: 10.1159/000365040. Epub 2014 Oct 2. Review.

PMID:
25300275

Supplemental Content

Support Center